January 2007
Worldwide Biotech;Jan2007, Vol. 19 Issue 1, p7
Trade Publication
The article reports that China Biopharmaceuticals Holdings Inc. has completed the required clinical trials for Desloratadine tablets for seasonal allergic rhinitis. The tablets are indicated for the relief of pruritus and the reduction in the number of hives in patients with chronic idiopathic urticaria. The remarks of COO Lufan An on the completion of trials are also presented.


Related Articles

  • Mims UPDATE.  // GP: General Practitioner;9/15/2003, p67 

    Aventis has launched a paediatric presentation of Telfast, fexofenadine, for seasonal rhinitis in children aged six toll years. In clinical trials in children of this age group, the most commonly reported adverse event was headache, but the incidence of 1 per cent was similar to that seen with...

  • INTRANASAL BUDESONIDE OR FLUTICASONE FOR ALLERGIC RHINITIS. Yedavally-Yellayi, Sri Kala; French, Linda // Journal of Family Practice;Apr1999, Vol. 48 Issue 4, p248 

    The article cites a research study that analyzes which intranasal steroid, budesonide or fluticasone, is more effective in controlling symptoms of perennial allergic rhinitis. Allergic rhinitis affects from 10% to 30% of the population of the United States. Intranasal corticosteroids have become...

  • Treating Seasonal Allergic Rhinitis with Butterbur Extract. Schapowal, A. // HerbalGram;Fall2002, Issue 56, p1 

    Focuses on the effectiveness of butterbur and cetirizine in treating seasonal allergic rhinitis. Accounts on the screening of patients with rhitinis for randomized, double blind trial; Characterization of allergic rhinitis; Management of symptoms associated with seasonal allergic rhinitis.

  • Efficacy of Desloratadine in Persistent Allergic Rhinitis - A GALEN Study. Bousquet, Jean; Bachert, Claus; Canonica, Giorgio W.; Mullol, Joaquim; Van Cauwenberge, Paul; Jensen, Carsten Bindslev; Fokkens, Wystke J.; Ring, Johannes; Keith, Paul; Gopalan, Gokul; Lorber, Richard; Zuberbier, Torsten // International Archives of Allergy & Immunology;2010, Vol. 153 Issue 4, p395 

    Background: The ARIA (Allergic Rhinitis and its Impact on Asthma) guidelines proposed a classification for allergic rhinitis based on the duration of symptoms (intermittent or persistent) rather than on the time of allergen exposure (seasonal or perennial). There had been no placebo-controlled,...

  • Inspire Nasal Spray Trial Fails and Program Halted. Hollingsworth, Catherine // BioWorld Today;4/24/2008, Vol. 19 Issue 80, p1 

    The article reports on the decision of Inspire Pharmaceuticals Inc. to stop development of its nasal spray epinastine for seasonal allergies. The move was announced after a Phase III clinical trial showed it did not work better than placebo. The study involves 798 patients, wherein epinastine...

  • Probiotics' effect against hayfever is not conclusive. Robinson, Nicholas // Food Manufacture;Jan2014, Vol. 89 Issue 1, p20 

    The article presents studies on the consumption of probiotic foods and its effect on people with hay fever. According to Kamal Ivory, a research scientist at the Institute of Food Research (IFR), many randomized controlled trials have shown that probiotic intake can improve quality of life and...

  • Desloratadine for Allergic Rhinitis. See, Sharon // American Family Physician;11/15/2003, Vol. 68 Issue 10, p2015 

    Features the desloratadine drug for seasonal and perennial allergic rhinitis and chronic idiopathic urticaria in patients 12 years of age and older. Safety and tolerability; Effectiveness; Price and simplicity.

  • Independent Nurse: Clinical Prescribing - Managing allergic rhinitis. Morris, David // GP: General Practitioner;5/7/2010, p23 

    The article offers information on drugs that can be used for managing allergic rhinitis. It states that allergic rhinitis has traditionally been divided into seasonal (hay fever), resulting principally from pollens and fungal spores, or perennial, arising commonly from house dust mite and pet...

  • Nasobec Hayfever.  // Royal Society of Medicine: Medicines;2002, p385 

    The article presents information on the antiallergic agent nasobec hayfever developed by IVAX. The drug can be used to relieve the symptoms of conditions such as hay fever and allergic and other types of rhinitis. It is available as nasal spray.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics